HUP1500218A2 - Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére - Google Patents

Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére

Info

Publication number
HUP1500218A2
HUP1500218A2 HU1500218A HUP1500218A HUP1500218A2 HU P1500218 A2 HUP1500218 A2 HU P1500218A2 HU 1500218 A HU1500218 A HU 1500218A HU P1500218 A HUP1500218 A HU P1500218A HU P1500218 A2 HUP1500218 A2 HU P1500218A2
Authority
HU
Hungary
Prior art keywords
cortilage
dysphoria
articular
injuries
treatment
Prior art date
Application number
HU1500218A
Other languages
English (en)
Inventor
Haracska Lajos Dr
Monostori Eva Dr
Kriston-Pal Eva Dr
Andrasne Gercso
Kovacs Katalin Illesne
Original Assignee
Deltabio 2000 Kft
Mta Szegedi Biolog Kutatokoezpont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deltabio 2000 Kft, Mta Szegedi Biolog Kutatokoezpont filed Critical Deltabio 2000 Kft
Priority to HU1500218A priority Critical patent/HUP1500218A2/hu
Priority to EP16020175.2A priority patent/EP3100738A1/en
Publication of HUP1500218A2 publication Critical patent/HUP1500218A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
HU1500218A 2015-05-08 2015-05-08 Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére HUP1500218A2 (hu)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1500218A HUP1500218A2 (hu) 2015-05-08 2015-05-08 Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére
EP16020175.2A EP3100738A1 (en) 2015-05-08 2016-05-09 Method and preparation for the treatment of articular cartilage injury comprising mesenchymal stem cells and hyaluronic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1500218A HUP1500218A2 (hu) 2015-05-08 2015-05-08 Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére

Publications (1)

Publication Number Publication Date
HUP1500218A2 true HUP1500218A2 (hu) 2016-11-28

Family

ID=89991815

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1500218A HUP1500218A2 (hu) 2015-05-08 2015-05-08 Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére

Country Status (2)

Country Link
EP (1) EP3100738A1 (hu)
HU (1) HUP1500218A2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3100466A1 (en) * 2018-06-05 2019-12-12 Medipost Co., Ltd. Pharmaceutical composition comprising hyaluronic acid and stem cells for treating cartilage damage-associated disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE288480T1 (de) 1995-11-16 2005-02-15 Univ Case Western Reserve Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
US20050074877A1 (en) 2003-07-28 2005-04-07 Mao Jeremy Jian Biological engineering of articular structures containing both cartilage and bone
US20130149285A1 (en) 2008-06-11 2013-06-13 Cell4Vet Corporation Adipose tissue-derived stem cells for veterinary use
US9795686B2 (en) 2012-01-19 2017-10-24 The Johns Hopkins University Biomaterials comprising hyaluronic acid binding peptides and bifunctional biopolymer molecules for hyaluronic acid retention and tissue engineering applications
US10724005B2 (en) 2012-09-28 2020-07-28 Scripps Health Methods of differentiating stem cells into chondrocytes
WO2014203269A2 (en) * 2013-06-17 2014-12-24 Kasiak Research Pvt. Ltd. Method for isolation, purification and industrial scale expansion of canine adipose tissue derived mesenchymal stem cells
US20160184364A1 (en) * 2013-08-14 2016-06-30 Stempeutics Research Pvt. Ltd. Management of osteoarthritis using pooled allogeneic mesenchymal stem cells

Also Published As

Publication number Publication date
EP3100738A1 (en) 2016-12-07

Similar Documents

Publication Publication Date Title
EP3349783C0 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES
HK1247838A1 (zh) 骨質疏鬆症的治療
IL246963A0 (en) A method and system for evaluating the effect of medical treatment
EP3390634A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES
HK1256903A1 (zh) 治療人免疫缺陷病毒的治療組合物
EP3341391A4 (en) COMPOSITIONS AND METHODS OF PAIN TREATMENT
IL257784A (en) Methods and compositions for reducing fat
EP3185905A4 (en) Compositions and methods for enhancing healing and regeneration of bone and soft tissue
SG10201402819WA (en) Composition for prevention and treatment of joint pain and the method of preparation thereof
IL249439A0 (en) A compound and method for the treatment of neurological diseases and brain injury
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
LT3200748T (lt) Kompozicijos ir būdai chirurginės operacijos vietos infekcijų gydymui ir profilaktikai
IL259710A (en) Preparations and methods for the treatment of Davidson's disease (microvillus inclusion disease) and related diseases
EP3253886A4 (en) Novel methods for early identification of bone healing ability in injured patients
HK1245094A1 (zh) 一種治療抑鬱症的藥物組合物及其製備方法
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
IL257336B (en) Pharmaceutical compounds and preparations for the prevention or treatment of parasitic diseases
EP2875820A4 (en) COMPOSITION AND METHOD FOR PROPHYLAXIS AND TREATMENT OF OSTEOPOROSIS AND BONE BREAKS
HK1246271A1 (zh) 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途
IL256919A (en) Pharmaceutical compositions useful for the treatment of tissue damage
IL252543A0 (en) Compounds for the treatment of degenerative retinal tissues
HUP1500218A2 (hu) Eljárás és készítmény ortopédiai betegségek, így ízületiporc-sérülések, különösen ízületi diszplázia kezelésére
DK3359209T3 (en) Compositions and methods for treatment of bone defects
GB201718483D0 (en) Pharmaceutical composition for treatment of meopausal syndrome and preparation method thereof
IL247369A0 (en) Compounds and methods for the treatment of bone diseases

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished